future of glp-1 drugs Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 Market Trends and Global
Description
So you see things like nausea, vomiting, gas, bloating, diarrhea, or constipation
Orforglipron has demonstrated substantial glucose-lowering efficacy across multiple Phase 2 and Phase 3 trials in type 2 diabetes
Some people need long-term medication or surgery
Diabetes 63 (10), 33463358
In other words, if this risk of thyroid cancer is real (and I think it is) we will potentially see an explosion in thyroid cancer and its related problems in the coming decade
L.et al (2022)
